Gene/Proteome Database (LMPD)
LMPD ID
LMP000385
Gene ID
Species
Homo sapiens (Human)
Gene Name
apolipoprotein A-I
Gene Symbol
Synonyms
-
Alternate Names
apolipoprotein A-I; apo-AI
Chromosome
11
Map Location
11q23-q24
Summary
This gene encodes apolipoprotein A-I, which is the major protein component of high density lipoprotein (HDL) in plasma. The protein promotes cholesterol efflux from tissues to the liver for excretion, and it is a cofactor for lecithin cholesterolacyltransferase (LCAT) which is responsible for the formation of most plasma cholesteryl esters. This gene is closely linked with two other apolipoprotein genes on chromosome 11. Defects in this gene are associated with HDL deficiencies, including Tangier disease, and with systemic non-neuropathic amyloidosis. [provided by RefSeq, Jul 2008]
Orthologs
Proteins
apolipoprotein A-I preproprotein | |
---|---|
Refseq ID | NP_000030 |
Protein GI | 4557321 |
UniProt ID | P02647 |
mRNA ID | NM_000039 |
Length | 267 |
RefSeq Status | REVIEWED |
MKAAVLTLAVLFLTGSQARHFWQQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAKVQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGARQKLHELQEKLSPLGEEMRDRARAHVDALRTHLAPYSDELRQRLAARLEALKENGGARLAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ | |
sig_peptide: 1..18 inference: COORDINATES: ab initio prediction:SignalP:4.0 calculated_mol_wt: 1834 peptide sequence: MKAAVLTLAVLFLTGSQA mat_peptide: 19..267 product: Proapolipoprotein A-I experiment: experimental evidence, no additional details recorded note: propagated from UniProtKB/Swiss-Prot (P02647.1) calculated_mol_wt: 28962 peptide sequence: RHFWQQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAKVQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGARQKLHELQEKLSPLGEEMRDRARAHVDALRTHLAPYSDELRQRLAARLEALKENGGARLAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ mat_peptide: 25..267 product: apolipoprotein A-I calculated_mol_wt: 28079 peptide sequence: DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAKVQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGARQKLHELQEKLSPLGEEMRDRARAHVDALRTHLAPYSDELRQRLAARLEALKENGGARLAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNTQ mat_peptide: 25..266 product: Truncated apolipoprotein A-I experiment: experimental evidence, no additional details recorded note: propagated from UniProtKB/Swiss-Prot (P02647.1) calculated_mol_wt: 27951 peptide sequence: DEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGSALGKQLNLKLLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAKVQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGARQKLHELQEKLSPLGEEMRDRARAHVDALRTHLAPYSDELRQRLAARLEALKENGGARLAEYHAKATEHLSTLSEKAKPALEDLRQGLLPVLESFKVSFLSALEEYTKKLNT |
Gene Information
Gene Ontology (GO Annotations)
GO ID | Source | Type | Description |
---|---|---|---|
GO:0072562 | IDA:UniProt | C | blood microparticle |
GO:0031410 | IDA:BHF-UCL | C | cytoplasmic vesicle |
GO:0005829 | TAS:Reactome | C | cytosol |
GO:0005769 | TAS:Reactome | C | early endosome |
GO:0030139 | IDA:BHF-UCL | C | endocytic vesicle |
GO:0071682 | TAS:Reactome | C | endocytic vesicle lumen |
GO:0005788 | TAS:Reactome | C | endoplasmic reticulum lumen |
GO:0005576 | TAS:Reactome | C | extracellular region |
GO:0005615 | IDA:BHF-UCL | C | extracellular space |
GO:0070062 | IDA:UniProtKB | C | extracellular vesicular exosome |
GO:0034364 | IDA:BHF-UCL | C | high-density lipoprotein particle |
GO:0005634 | IEA:Ensembl | C | nucleus |
GO:0005886 | TAS:Reactome | C | plasma membrane |
GO:0034774 | TAS:Reactome | C | secretory granule lumen |
GO:0034366 | IDA:BHF-UCL | C | spherical high-density lipoprotein particle |
GO:0034361 | IDA:BHF-UCL | C | very-low-density lipoprotein particle |
GO:0031982 | IDA:UniProtKB | C | vesicle |
GO:0034191 | IPI:BHF-UCL | F | apolipoprotein A-I receptor binding |
GO:0034190 | IPI:BHF-UCL | F | apolipoprotein receptor binding |
GO:0001540 | IDA:BHF-UCL | F | beta-amyloid binding |
GO:0045499 | IDA:UniProtKB | F | chemorepellent activity |
GO:0015485 | IDA:BHF-UCL | F | cholesterol binding |
GO:0017127 | IMP:BHF-UCL | F | cholesterol transporter activity |
GO:0019899 | IPI:BHF-UCL | F | enzyme binding |
GO:0008035 | IEA:Ensembl | F | high-density lipoprotein particle binding |
GO:0070653 | IPI:BHF-UCL | F | high-density lipoprotein particle receptor binding |
GO:0042802 | IPI:IntAct | F | identical protein binding |
GO:0055102 | IEA:Ensembl | F | lipase inhibitor activity |
GO:0060228 | IDA:BHF-UCL | F | phosphatidylcholine-sterol O-acyltransferase activator activity |
GO:0005543 | IDA:BHF-UCL | F | phospholipid binding |
GO:0005548 | IEA:Ensembl | F | phospholipid transporter activity |
GO:0007186 | IDA:BHF-UCL | P | G-protein coupled receptor signaling pathway |
GO:0030325 | IEA:Ensembl | P | adrenal gland development |
GO:0007596 | TAS:Reactome | P | blood coagulation |
GO:0043534 | IEA:Ensembl | P | blood vessel endothelial cell migration |
GO:0044255 | TAS:Reactome | P | cellular lipid metabolic process |
GO:0006695 | IEA:Ensembl | P | cholesterol biosynthetic process |
GO:0033344 | IDA:BHF-UCL | P | cholesterol efflux |
GO:0042632 | IDA:BHF-UCL | P | cholesterol homeostasis |
GO:0070508 | IMP:BHF-UCL | P | cholesterol import |
GO:0008203 | IMP:BHF-UCL | P | cholesterol metabolic process |
GO:0030301 | IDA:MGI | P | cholesterol transport |
GO:0001935 | IEA:Ensembl | P | endothelial cell proliferation |
GO:0008211 | IEA:Ensembl | P | glucocorticoid metabolic process |
GO:0034380 | IDA:BHF-UCL | P | high-density lipoprotein particle assembly |
GO:0034384 | IC:BHF-UCL | P | high-density lipoprotein particle clearance |
GO:0034375 | IC:BHF-UCL | P | high-density lipoprotein particle remodeling |
GO:0007229 | IDA:UniProtKB | P | integrin-mediated signaling pathway |
GO:0019915 | IEA:Ensembl | P | lipid storage |
GO:0042158 | IEA:Ensembl | P | lipoprotein biosynthetic process |
GO:0042157 | TAS:Reactome | P | lipoprotein metabolic process |
GO:0050919 | IDA:UniProtKB | P | negative chemotaxis |
GO:0060354 | IDA:BHF-UCL | P | negative regulation of cell adhesion molecule production |
GO:0002740 | IDA:BHF-UCL | P | negative regulation of cytokine secretion involved in immune response |
GO:0034115 | IDA:BHF-UCL | P | negative regulation of heterotypic cell-cell adhesion |
GO:0050728 | IDA:BHF-UCL | P | negative regulation of inflammatory response |
GO:0050713 | IDA:BHF-UCL | P | negative regulation of interleukin-1 beta secretion |
GO:0060192 | IEA:Ensembl | P | negative regulation of lipase activity |
GO:0060761 | IDA:BHF-UCL | P | negative regulation of response to cytokine stimulus |
GO:0010804 | IDA:BHF-UCL | P | negative regulation of tumor necrosis factor-mediated signaling pathway |
GO:0010903 | IDA:BHF-UCL | P | negative regulation of very-low-density lipoprotein particle remodeling |
GO:0031100 | IEA:Ensembl | P | organ regeneration |
GO:0018206 | IDA:UniProtKB | P | peptidyl-methionine modification |
GO:0014012 | IEA:Ensembl | P | peripheral nervous system axon regeneration |
GO:0006656 | IDA:BHF-UCL | P | phosphatidylcholine biosynthetic process |
GO:0033700 | IDA:BHF-UCL | P | phospholipid efflux |
GO:0055091 | IDA:BHF-UCL | P | phospholipid homeostasis |
GO:0007603 | TAS:Reactome | P | phototransduction, visible light |
GO:0030168 | TAS:Reactome | P | platelet activation |
GO:0002576 | TAS:Reactome | P | platelet degranulation |
GO:0035025 | IDA:UniProtKB | P | positive regulation of Rho protein signal transduction |
GO:0010873 | IDA:BHF-UCL | P | positive regulation of cholesterol esterification |
GO:0051345 | IDA:BHF-UCL | P | positive regulation of hydrolase activity |
GO:0051496 | IDA:UniProtKB | P | positive regulation of stress fiber assembly |
GO:1900026 | IDA:UniProtKB | P | positive regulation of substrate adhesion-dependent cell spreading |
GO:0051347 | IEA:Ensembl | P | positive regulation of transferase activity |
GO:0018158 | IDA:UniProtKB | P | protein oxidation |
GO:0050821 | IDA:BHF-UCL | P | protein stabilization |
GO:0032489 | IDA:BHF-UCL | P | regulation of Cdc42 protein signal transduction |
GO:0030300 | IEA:Ensembl | P | regulation of intestinal cholesterol absorption |
GO:0001932 | IEA:Ensembl | P | regulation of protein phosphorylation |
GO:0042493 | IEA:Ensembl | P | response to drug |
GO:0043627 | IEA:Ensembl | P | response to estrogen |
GO:0007584 | IEA:Ensembl | P | response to nutrient |
GO:0001523 | TAS:Reactome | P | retinoid metabolic process |
GO:0043691 | IMP:BHF-UCL | P | reverse cholesterol transport |
GO:0044281 | TAS:Reactome | P | small molecule metabolic process |
GO:0055085 | TAS:Reactome | P | transmembrane transport |
GO:0070328 | IDA:BHF-UCL | P | triglyceride homeostasis |
KEGG Pathway Links
Domain Information
InterPro Annotations
Accession | Description |
---|---|
IPR000074 | Apolipoprotein A/E |
UniProt Annotations
Entry Information
Comments
Comment Type | Description |
---|---|
Disease | Amyloidosis 8 (AMYL8) [MIM |
Disease | High density lipoprotein deficiency 1 (HDLD1) [MIM |
Disease | High density lipoprotein deficiency 2 (HDLD2) [MIM |
Disease | Note=APOA1 mutations may be involved in the pathogenesis of amyloid polyneuropathy-nephropathy Iowa type, also known as amyloidosis van Allen type or familial amyloid polyneuropathy type III (PubMed:3142462 and PubMed:2123470). The clinical picture is dominated by neuropathy in the early stages of the disease and nephropathy late in the course. Death is due in most cases to renal amyloidosis. |
Function | Participates in the reverse transport of cholesterol from tissues to the liver for excretion by promoting cholesterol efflux from tissues and by acting as a cofactor for the lecithin cholesterol acyltransferase (LCAT). As part of the SPAP complex, activates spermatozoa motility. |
Interaction | Self; NbExp=12; IntAct=EBI-701692, EBI-701692; O95477:ABCA1; NbExp=4; IntAct=EBI-701692, EBI-784112; P05067:APP; NbExp=5; IntAct=EBI-701692, EBI-77613; P02671:FGA; NbExp=2; IntAct=EBI-701692, EBI-348571; P00738:HP; NbExp=3; IntAct=EBI-701692, EBI-1220767; |
Mass Spectrometry | Mass=28081; Method=Electrospray; Range=25-267; Note=Without methionine sulfoxide.; Evidence= ; |
Mass Spectrometry | Mass=28095; Method=Electrospray; Range=25-267; Note=With 1 methionine sulfoxide, oxidation at Met-136.; Evidence= ; |
Mass Spectrometry | Mass=28098; Method=Electrospray; Range=25-267; Note=With 1 methionine sulfoxide, oxidation at Met-110.; Evidence= ; |
Mass Spectrometry | Mass=28114; Method=Electrospray; Range=25-267; Note=With 2 methionine sulfoxides, oxidation at Met-110 and Met- 136.; Evidence= ; |
Polymorphism | Genetic variations in APOA1 can result in APOA1 deficiency and are associated with low levels of HDL cholesterol [MIM |
Ptm | Glycosylated. |
Ptm | Palmitoylated. |
Ptm | Phosphorylation sites are present in the extracellular medium. |
Similarity | Belongs to the apolipoprotein A1/A4/E family. |
Subcellular Location | Secreted. |
Subunit | Interacts with APOA1BP and CLU. Component of a sperm activating protein complex (SPAP), consisting of APOA1, an immunoglobulin heavy chain, an immunoglobulin light chain and albumin. Interacts with NDRG1. {ECO |
Tissue Specificity | Major protein of plasma HDL, also found in chylomicrons. Synthesized in the liver and small intestine. The oxidized form at Met-110 and Met-136 is increased in individuals with increased risk for coronary artery disease, such as in carrier of the eNOSa/b genotype and exposure to cigarette smoking. It is also present in increased levels in aortic lesions relative to native ApoA-I and increased levels are seen with increasing severity of disease. |
Web Resource | Name=SHMPD; Note=The Singapore human mutation and polymorphism database; URL="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=APOA1"; |
Identical and Related Proteins
Unique RefSeq proteins for LMP000385 (as displayed in Record Overview)
Protein GI | Database | Accession | Length | Protein Name |
---|---|---|---|---|
4557321 | RefSeq | NP_000030 | 267 | apolipoprotein A-I preproprotein |
Identical Sequences to LMP000385 proteins
Reference | Database | Accession | Length | Protein Name |
---|---|---|---|---|
GI:4557321 | GenBank | AGP16938.1 | 267 | Sequence 1 from patent US 8460889 |
GI:4557321 | GenBank | AGX47856.1 | 267 | Sequence 2 from patent US 8541236 |
GI:4557321 | GenBank | AHE01107.1 | 267 | Sequence 56023 from patent US 8586006 |
GI:4557321 | GenBank | AIC48276.1 | 267 | APOA1, partial [synthetic construct] |
GI:4557321 | RefSeq | XP_005271596.1 | 267 | PREDICTED: apolipoprotein A-I isoform X1 [Homo sapiens] |
GI:4557321 | RefSeq | XP_005271597.1 | 267 | PREDICTED: apolipoprotein A-I isoform X2 [Homo sapiens] |
Related Sequences to LMP000385 proteins
Reference | Database | Accession | Length | Protein Name |
---|---|---|---|---|
GI:4557321 | GenBank | AAA35545.1 | 267 | proapo-A-I protein [Homo sapiens] |
GI:4557321 | GenBank | AAV38908.1 | 268 | apolipoprotein A-I, partial [synthetic construct] |
GI:4557321 | GenBank | AAV38929.1 | 268 | apolipoprotein A-I, partial [synthetic construct] |
GI:4557321 | GenBank | AAX42892.1 | 268 | apolipoprotein A-I, partial [synthetic construct] |
GI:4557321 | GenBank | AAX42893.1 | 268 | apolipoprotein A-I, partial [synthetic construct] |
GI:4557321 | GenBank | AGB62516.1 | 296 | Sequence 77 from patent US 8288091 |